Fundraising Fox

Stemgenics

Seattle, US · Washington corporation

Biotech

Founders & leadership

FS
Frederick S HagenExecutive
MH
Mushegh HovhannisyanExecutive
AA
Andranik AprikyanNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3.3M disclosed across 3 rounds · 2013–2018

▶$445KraisedJul 2018 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mushegh HovhannisyanExecutive Officer, Director
  • Frederick S HagenExecutive Officer, Director
  • Andranik AprikyanExecutive Officer, Director
  • Anush OganesianDirector
Offering amount
$20M
Amount sold
$445K
Proceeds to insiders
$1.2M
Placement agents
Endeavor Capital Management Holdings, Frederick S. Hagen
First sale
Jun 2018
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.8MraisedJan 2018 · 39 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick S HagenExecutive Officer, Director
  • Andranik AprikyanExecutive Officer, Director
  • Mushegh HovhannisyanExecutive Officer, Director
Offering amount
$1.8M
Amount sold
$1.8M
First sale
Dec 2015
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.1MraisedJan 2014 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mushegh HovhannisyanExecutive Officer, Director
  • Frederick HagenExecutive Officer, Director
  • Andranik AprikyanExecutive Officer, Director
Offering amount
$1.1M
Amount sold
$1.1M
Proceeds to insiders
$150K
First sale
Dec 2013
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Stemgenics raised?
Stemgenics has disclosed $3.3M raised across 3 rounds.
Where is Stemgenics headquartered?
Stemgenics is headquartered in Seattle, US.